ArticleFrontiers in immunology2026

An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C-IV non-squamous NSCLC.

Shanshan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.